Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julia Arfi-Rouche

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 29, 2017
Are we reproducible in measurement of NET liver metastasis?Salma Moalla, Julia Arfi Rouche, Stéphanie Foulon, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 22, 2017
Poor predictive value of positive interim FDG-PET/CT in primary mediastinal large B-cell lymphomaJulien Lazarovici, Marie Terroir, Julia Arfi-Rouche, et al.
Clinical and Translational Radiation Oncology|August 11, 2018
Helping patients make informed decisions. Two-year evaluation of the Gustave Roussy prostate cancer multidisciplinary clinicAnna Patrikidou, Pierre Maroun, Jean-Jacques Patard, et al.
Leukemia & Lymphoma|November 23, 2017
A retrospective, matched paired analysis comparing bendamustine containing BeEAM versus BEAM conditioning regimen: results from a single center experienceKhalil Saleh, Alina Danu, Serge Koscielny, et al.
Neuroendocrinology|May 27, 2016
Not All Patients with a Pancreatic Neuroendocrine Tumour Will Benefit from All Approved or Recommended Therapeutic Options: A Real-Life Retrospective StudyAmandine Berdelou, Valérie Boige, Julia Arfi-Rouche, et al.
Bulletin Du Cancer|January 1, 2018
[Hodgkin lymphoma: Current and future therapeutic strategies]Anthony Turpin, Jean-Marie Michot, Emmanuelle Kempf, et al.
European Journal of Cancer (Oxford, England : 1990)|August 7, 2023
Efficacy and safety of crizotinib in ALK-positive systemic anaplastic large-cell lymphoma in children, adolescents, and adult patients: results of the French AcSé-crizotinib trialLaurence Brugières, Nathalie Cozic, Roch Houot, et al.
American Journal of Hematology|June 24, 2021
Innovative therapies based on molecular orientation in patients with relapse and refractory diffuse large B-cell lymphoma: Results of LNH-EP1 studyClémentine Sarkozy, Jean-Marie Michot, Cyril Quivoron, et al.
European Journal of Cancer (Oxford, England : 1990)|August 30, 2016
The challenge of rapid diagnosis in oncology: Diagnostic accuracy and cost analysis of a large-scale one-stop breast clinicSuzette Delaloge, Julia Bonastre, Isabelle Borget, et al.
American Journal of Hematology|January 6, 2023
Sequence analyses of relapsed or refractory diffuse large B-cell lymphomas unravel three genetic subgroups of patients and the GNA13 mutant as poor prognostic biomarker, results of LNH-EP1 studyJean-Marie Michot, Cyril Quivoron, Clémentine Sarkozy, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 29, 2017
Are we reproducible in measurement of NET liver metastasis?Salma Moalla, Julia Arfi Rouche, Stéphanie Foulon, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 22, 2017
Poor predictive value of positive interim FDG-PET/CT in primary mediastinal large B-cell lymphomaJulien Lazarovici, Marie Terroir, Julia Arfi-Rouche, et al.
Clinical and Translational Radiation Oncology|August 11, 2018
Helping patients make informed decisions. Two-year evaluation of the Gustave Roussy prostate cancer multidisciplinary clinicAnna Patrikidou, Pierre Maroun, Jean-Jacques Patard, et al.
Leukemia & Lymphoma|November 23, 2017
A retrospective, matched paired analysis comparing bendamustine containing BeEAM versus BEAM conditioning regimen: results from a single center experienceKhalil Saleh, Alina Danu, Serge Koscielny, et al.
Neuroendocrinology|May 27, 2016
Not All Patients with a Pancreatic Neuroendocrine Tumour Will Benefit from All Approved or Recommended Therapeutic Options: A Real-Life Retrospective StudyAmandine Berdelou, Valérie Boige, Julia Arfi-Rouche, et al.
Bulletin Du Cancer|January 1, 2018
[Hodgkin lymphoma: Current and future therapeutic strategies]Anthony Turpin, Jean-Marie Michot, Emmanuelle Kempf, et al.
European Journal of Cancer (Oxford, England : 1990)|August 7, 2023
Efficacy and safety of crizotinib in ALK-positive systemic anaplastic large-cell lymphoma in children, adolescents, and adult patients: results of the French AcSé-crizotinib trialLaurence Brugières, Nathalie Cozic, Roch Houot, et al.
American Journal of Hematology|June 24, 2021
Innovative therapies based on molecular orientation in patients with relapse and refractory diffuse large B-cell lymphoma: Results of LNH-EP1 studyClémentine Sarkozy, Jean-Marie Michot, Cyril Quivoron, et al.
European Journal of Cancer (Oxford, England : 1990)|August 30, 2016
The challenge of rapid diagnosis in oncology: Diagnostic accuracy and cost analysis of a large-scale one-stop breast clinicSuzette Delaloge, Julia Bonastre, Isabelle Borget, et al.
American Journal of Hematology|January 6, 2023
Sequence analyses of relapsed or refractory diffuse large B-cell lymphomas unravel three genetic subgroups of patients and the GNA13 mutant as poor prognostic biomarker, results of LNH-EP1 studyJean-Marie Michot, Cyril Quivoron, Clémentine Sarkozy, et al.
Pageof 2